PET and SPECT Exploration of Central Monoaminergic Transporters for the Development of New Drugs and Treatments in Brain Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|25|3237-3245

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.25, 2005-10, pp. : 3237-3245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders

By Taylor E.M.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite

PET Studies of Brain Monoamine Transporters.

By  

Current Pharmaceutical Design, Vol. 6, Iss. 16, 2000-11 ,pp. : 1611-1623

Bentham Science Publishers

Access to resources Recommend Favorite

Quantification of SPECT and PET for Drug Development

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 17-21

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Monoaminergic Transporters by Choline-Containing Phospholipids in Rat Brain

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 94-103

Bentham Science Publishers

Access to resources Recommend Favorite

PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In Vivo

By  

Current Drug Metabolism, Vol. 12, Iss. 8, 2011-10 ,pp. : 774-792

Bentham Science Publishers

Access to resources Recommend Favorite